About the Conference

Welcome to the 19th International Conference on Alzheimer's Disease and Dementia, set to take place on August 04-05, 2025, in Berlin, Germany. Under the theme "Rethinking Memory: Future Directions in Alzheimer's Diagnosis, Treatment, and Care," this conference provides a vital platform for professionals from diverse disciplines to come together and share their latest research, insights, and innovations in the field of Alzheimer's and dementia care. Alzheimer's disease and other forms of dementia are growing public health concerns worldwide, affecting millions of individuals and their families. The urgency to find effective diagnostic tools, treatments, and comprehensive care strategies has never been greater. This conference will gather a multidisciplinary audience, including neurologists, psychiatrists, researchers, clinicians, healthcare providers, caregivers, and advocates, all dedicated to improving the lives of those affected by these neurodegenerative diseases.

Abstract submissions and registration are now open. Present your research and register early to join this global Alzheimer's conference.

Why Attend?

This conference offers a unique opportunity to immerse yourself in the latest scientific knowledge and technological advancements in Alzheimer's research. Here’s why you should be part of this event:

• Discover Cutting-Edge Research: Learn about the latest breakthroughs in the understanding of Alzheimer's disease, from genetics and molecular biology to clinical trials and emerging therapies.
• Explore Innovative Treatments: Hear about new approaches to slowing the progression of the disease, managing symptoms, and improving patient outcomes.
• Gain Practical Insights: Whether you're a healthcare professional looking for effective patient care strategies or a researcher seeking the latest scientific data, the conference offers practical solutions that can be applied in real-world settings.
• Engage with Global Experts: Network with leading professionals from around the globe. Engage in meaningful discussions, collaborate on research, and explore opportunities for future partnerships.

Who Should Attend?

Session and Tracks

Track 1. Early Diagnosis andBiomarkers: Shaping the Future of Detection 

Track 2. Neuroinflammation: The Silent Driver of Alzheimer’s Pathology

Track 3. Genetics and Epigenetics: Understanding Alzheimer’s Risk

Track 4. Targeting Amyloid and Tau: Current and Emerging Therapies

Track 5. Cognitive Rehabilitation and Enhancing Neuroplasticity

Track 6. Lifestyle Interventions: Prevention through Diet, Exercise, and Social Engagement

Track 7. The Gut-Brain Axis: A New Frontier in Alzheimer’s Research

Track 8. Advanced Drug Delivery Systems: Crossing the Blood-Brain Barrier

Track 9. Personalized Medicine in Alzheimer’s Disease: Tailoring Treatment to Individuals

Track 10. Non-Pharmacological Interventions in Dementia Care: Beyond Medications

Track 11. Artificial Intelligence and Machine Learning in Alzheimer’s Care

Track 12. Caregiver Burden and Support: Strategies for Resilience and Coping

Track 13. Sex Differences in Alzheimer’s Disease: Understanding the Gender Gap

Track 14. Alzheimer’s Disease in Low- and Middle-Income Countries: Overcoming Global Challenges

Track 15. Innovations in Clinical Trials: Accelerating Alzheimer’s Research

Participant Options & Benefits

• Oral Presentations: Showcase your research and findings to a global audience of experts and receive feedback from peers and mentors.
• Poster Sessions: Share your research through a poster presentation and engage with colleagues and industry leaders in a more informal setting.
• Networking Opportunities: Take part in social events designed to foster collaboration, share ideas, and build lasting professional relationships.
• Exhibitions: Explore the latest technologies, tools, and services that are revolutionizing the field of Alzheimer's and dementia care.
• Certification: Attendees will receive a certificate of participation, recognizing their involvement in the global effort to address Alzheimer’s and dementia.

Societies and Associations

A number of prominent societies, organizations, and associations play a significant role in supporting Alzheimer's research, patient care, and advocacy. These groups often collaborate in global conferences like this one, and their members contribute through presentations, research sharing, and workshops. Some of the key societies and associations likely to be involved in or associated with the conference include:

1. Alzheimer's Association (AA)

• The Alzheimer's Association is a leading voluntary health organization supporting Alzheimer's care, research, and education. It plays a pivotal role in advocating for better public awareness, patient support, and fundraising for Alzheimer’s research initiatives.

2. Dementia Action Alliance (DAA)

• The Dementia Action Alliance works towards improving the quality of life for people living with dementia through collaborative efforts in research, care practices, and public policies. The alliance fosters connections between researchers, healthcare professionals, and dementia advocates.

3. European Alzheimer's Disease Consortium (EADC)

• The EADC is a network of European research centers dedicated to understanding the biological mechanisms of Alzheimer’s disease and dementia. Their collaboration on clinical trials and research initiatives contributes significantly to the development of new therapies.

4. International Society to Advance Alzheimer’s Research and Treatment (ISTAART)

• The ISTAART is a professional society under the Alzheimer’s Association that connects individuals engaged in Alzheimer’s and dementia science across the globe. It promotes collaboration among professionals in basic, translational, and clinical research fields.

5. World Federation of Neurology (WFN)

• The WFN supports the development of neurological services, education, and research with a global perspective. They contribute to Alzheimer’s and dementia care through specialized neurological expertise and collaboration with Alzheimer's researchers.

6. Global Brain Health Institute (GBHI)

• The GBHI is a global organization focused on protecting brain health and reducing the scale and impact of dementia. The institute promotes research and advocacy on Alzheimer's disease while fostering international collaboration in dementia prevention.

7. International Psychogeriatric Association (IPA)

• The IPA is dedicated to improving the mental health of older people, including those affected by dementia. Their work includes advancing psychogeriatric care and fostering research collaborations aimed at enhancing dementia diagnosis and treatment.

8. European Federation of Neurological Societies (EFNS)

• The EFNS plays an essential role in neurology research, including Alzheimer's disease. The society provides a platform for European neurologists to share research and best practices in dementia care.

9. Alzheimer Europe

• Alzheimer Europe is a non-governmental organization aimed at making dementia a European public health priority. They work closely with national Alzheimer’s associations and provide a voice for people living with dementia, influencing policy and research across Europe.

Role of These Societies and Associations in the Conference

These organizations, along with several other national and international bodies, will be instrumental in shaping the discussions and directions taken at the conference. Their contributions will include:

• Sponsorship and Support: Many of these organizations provide financial support and sponsor research initiatives presented at the conference.
• Scientific Contributions: Members from these societies often present the latest research findings, including clinical trials, disease mechanisms, and new therapeutic approaches.
• Workshops and Symposia: Some societies and associations may host special symposia or workshops during the conference, providing focused training or in-depth discussions on Alzheimer’s research and care.
• Networking and Collaboration Opportunities: The conference will offer participants opportunities to connect with members of these organizations for future research collaborations, professional development, and patient care initiatives.

The presence of these societies and associations at the 19th International Conference on Alzheimer's Disease and Dementia ensures a comprehensive and collaborative effort in advancing the understanding, treatment, and care of Alzheimer's disease and related dementias.